|
|
|
Genaissance Pharmaceuticals Signs Agreement with Pfizer
|
Business New Haven
11/26/2001
By: Lisa Micali
|
NEW HAVEN - Genaissance Pharmaceuticals Inc. (NASDAQ: GNSC) announced that it has entered into an agreement with Pfizer Inc. (NYSE: PFE) in which Pfizer will gain access to selected data from Genaissance's HAP database, the world's most comprehensive collection of markers of gene variation. These markers, known as haplotypes or HAP Markers, are akin to genomic bar codes and represent the pattern and organization of DNA variability that each individual inherits. Genaissance has pioneered the industrialization of haplotype discovery for the personalization of health care. Genaissance has already discovered over 80,000 haplotypes from nearly 5,000 genes and intends to discover the haplotypes for all human genes.
|
Go FirstGo PreviousGo
NextGo LastGo
to Index
|
|
